PRECLINICAL EVALUATION OF ABBV-838, A FIRST-IN-CLASS ANTI-CS1 ANTIBODY-DRUG CONJUGATE FOR THE TREATMENT OF MULTIPLE MYELOMA

K. Gish, H. Kim, R. Power,M. Fox,J. Hickson,T. McGonigal,D. Chao,M. Sho, H. Singh, E. Tarcsa,W. Gao, L. Loberg, C. Allan, C. Becker, R. Duffy, R. Nath,D. Afar

HAEMATOLOGICA（2016）

Cited 0|Views17

No score

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined